日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis

C3肾小球病和原发性(特发性)免疫复合物膜增生性肾小球肾炎的现有及新兴疗法

Kavanagh, David; Ariceta, Gema; Vivarelli, Marina; Schaefer, Franz; Caravaca-Fontán, Fernando; Frémeaux-Bacchi, Véronique; Fakhouri, Fadi; Licht, Christoph; Pickering, Matthew C

C3 Glomerulonephritis Associated With Anti-complement Factor B Antibodies Following Anti-cancer Treatment With Pembrolizumab

接受帕博利珠单抗抗癌治疗后,出现与抗补体因子B抗体相关的C3肾小球肾炎

Stroppou, Persia; Asaelof, Lucia; Panayides, Alexia; Arsali, Maria; Spartalis, Michalis; Kevrekidou, Sophia; Christofi, Themis; Theophanous, Theophanis; Michaelides, Constantinos; Marchbank, Kevin J; Dimitriou, Kyproula; Kavanagh, David; Mitsides, Nicos

Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUS

终身使用依库珠单抗治疗非典型溶血性尿毒综合征与疾病监测的成本效益比较

Orozco-Leal, Giovany; Vale, Luke; Oluboyede, Yemi; Brocklebank, Victoria; Bryant, Andy; Chadwick, Tom; Dunn, Sarah; Johnson, Sally; Kavanagh, David; Kennedy, Ciara; Lecouturier, Jan; Weetman, Chris; Wong, Edwin; Woodward, Len; Sheerin, Neil S

Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study

非典型溶血性尿毒综合征患者停用依库珠单抗的临床和成本效益:SETS aHUS 多中心、开放标签、前瞻性单臂研究

Bryant, Andrew; Lecouturier, Jan; Orozco-Leal, Giovany; Brocklebank, Vicky; Carnell, Sonya; Chadwick, Thomas J; Dunn, Sarah; Johnson, Sally A; Kavanagh, David; Kennedy, Ciara A; Malina, Michal; Montgomery, Emma K; Muirhead, Colin R; Oluboyede, Yemi; Vale, Luke; Weetman, Chris; Kwan Soon Wong, Edwin; Woodward, Len; Sheerin, Neil S

Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease.

TREX1 外切酶活性异常但完整,会导致人类脑部和全身小血管疾病

McGlasson Sarah, Reid Katy, Klingseisen Anna, Rioux Bastien, Chauvin Samuel, Miner Cathrine A, Holley Joe, Forbes Deborah, Geary Bethany, Kimber Jeffrey, Wood Katrina, Roufosse Candice, Smith Colin, Kavanagh David, Miner Jonathan, Hunt David P J

Post-transplant Thrombotic Microangiopathy

移植后血栓性微血管病

Java, Anuja; Sparks, Matthew A; Kavanagh, David

Factor B as a therapeutic target for the treatment of complement-mediated diseases

因子B作为治疗补体介导疾病的治疗靶点

Kavanagh, David; Barratt, Jonathan; Schubart, Anna; Webb, Nicholas J A; Meier, Matthias; Fakhouri, Fadi

Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

培塞他考普兰治疗复发性补体3肾小球病或原发性免疫复合物膜增生性肾小球肾炎肾移植受者的疗效和安全性

Bomback, Andrew S; Daina, Erica; Remuzzi, Giuseppe; Kanellis, John; Kavanagh, David; Pickering, Matthew C; Sunder-Plassmann, Gere; Walker, Patrick D; Wang, Zhongshen; Ahmad, Zurish; Fakhouri, Fadi

Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes

血栓性微血管病亚型中肾脏补体免疫组织化学

Beckwith, Hannah; Medjeral-Thomas, Nicholas; Kwiatkowska, Karolina; Kavanagh, David; Pickering, Matthew C; Smith, Andrew; Cook, H Terence; Pusey, Charles D

Kidney Transplantation in Patients With aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue Therapy

肾移植治疗非典型溶血性尿毒综合征(aHUS):依库珠单抗预防与抢救治疗的比较

Duineveld, Caroline; Glover, Emily K; Bouwmeester, Romy N; van de Kar, Nicole C A J; Kavanagh, David; Wetzels, Jack F M; Sheerin, Neil S